Skip to header Skip to main content Skip to footer

Search for product, molecule, disease…

Privacy Policy

Boehringer Ingelheim International GmbH (hereafter "Boehringer Ingelheim", "we", "our", "us") takes the protection of your personal data seriously. This Privacy Policy describes how we use, store and disclose (together "process") the personal data we collect about you through this website. The nature, extent and purposes for which we process your personal data depends on your use of this website. In any event, we will only process your personal data in accordance with applicable data protection and privacy laws (i.a. the General Data Protection Regulation).

1. General Privacy Notice

We process your data in order to provide you with the agreed or requested services on this website:

  • If you register and log in;
  • if you take part in training courses or events;
  • if you send us inquiries about products or possible adverse event.

The legal basis is Article 6 (1) b) GDPR and Article 6 (1) c) GDPR if you send information about possible adverse events (see Section 7 for specific information about adverse events).

2. Data Transfer

We may share personal information with third parties.

2.1 Reporting obligations to regulatory authorities and enforcement of rights

We may share personal data in pharmacovigilance cases as specified in Section 5.

In order to protect our rights or the rights of third parties, we may also disclose data to rights holders, consultants and authorities in accordance with legal provisions..

2.2 Boehringer Ingelheim companies

As part of a global group of companies, we involve other Boehringer Ingelheim companies that support us in data processing. These group companies process the data exclusively for the purposes stated in this data protection declaration.

2.3 Data transfer to recipients outside the EU

Some of these service providers and Boehringer companies process personal data outside the EU. In these cases, we ensure an adequate level of data protection to comply with European law (usually through EU standard contractual clauses published by the European Commission).

2.4 Data transfer to recipients outside the EU

Some of these service providers and Boehringer companies process personal data outside the EU. In these cases, we ensure an adequate level of data protection to comply with European law (usually through EU standard contractual clauses published by the European Commission).

3. Specific Privacy Notice for Pharmacovigilance

If you report adverse events or other pharmacovigilance relevant information to a Boehringer Ingelheim product we will use and share this data solely for pharmacovigilance purposes. (Pharmacovigilance is the detection, assessment, understanding and prevention of adverse effects or any other medicine-related problem.)
All reports will be shared with Boehringer Ingelheim International GmbH who is operating the global pharmacovigilance database.
Boehringer Ingelheim is obliged to report pharmacovigilance relevant information to health authorities worldwide (including to countries that may have another level of data protection compared to the EU). Legal basis: Art. 6 (1) c), and for transfers outside EU Art. 6 (1) f) and Art. 49 (1) e) GDPR.
The reports will contain details about the incident but only limited personal data:

  • For Patients, the report will only contain, age, gender and initials as provided, but never the patient's name.
  • For the reporting individuals, the report will include the name, profession (e.g. physician, pharmacist), initials or address, e-mail and phone number as provided. The contact information is required to be able to follow-up with the reporter to gain high quality and complete information on adverse events. If the reporter does not wish to provide his contact details to Boehringer Ingelheim or authorities, “Privacy” is entered in reporter's names field. 

Where your data is shared with other Boehringer Ingelheim companies, business partners or service providers outside of the EU, we will provide an adequate protection of personal data.
As reports about adverse events are important for public health reasons, reports are kept for minimum of 10 years after withdrawal of the product in the last country where the product is marketed.

4. Deletion

Boehringer Ingelheim processes your personal data for as long as necessary for the purpose of the processing, which mainly is the provision of our services requested by you. This means for example that we send you newsletters for as long as you did not withdraw your subscription or that we store your user account data (login, profession, name etc.) for as long as you maintain a user account with us.
We will retain personal information for as long as necessary for the particular business purpose or purposes for which it was collected. If you revoke your consent, delete user accounts or object to data processing, we will delete the data collected in a timely manner.
In some cases we are obliged to keep data to comply with statutory retention periods (e.g. in the context of pharmacovigilance). In such a case, we will ensure that your data will only be used to comply with the retention obligations and not for other purposes.

5. Your Rights

Subject to limitations in applicable law, you have a right of access, rectification, restriction, erasure, and portability of your personal data, as well as the right not to be subject to automated individual decision-making.
You also have the right to withdraw your consent at any time.

Right to object:

To the extent we base the tracking on our legitimate interests, you may opt-out from such processing at any time. You may also object to the processing of your personal data for the transfer to authorities outside the EU described above in Section 5 for pharmacovigilance cases unless the interests of Boehringer Ingelheim prevail.
Please send your request or any question you have in relation to our processing of your personal data to:

Boehringer Ingelheim International GmbH

- Data Protection Officer -
Binger Straße 173
D-55216 Ingelheim am Rhein
Germany

E-mail: [email protected]

If you still have concerns, you may have a right to lodge a complaint to the supervisory authority for privacy in your country.